Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,578
archived clinical trials in
Skin and Soft Tissue Infections

Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Status: Enrolling
Updated:  7/19/2011
Saint Elizabeth Regional Burn and Wound Center
mi
from
Lincoln, NE
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Status: Enrolling
Updated: 7/19/2011
Saint Elizabeth Regional Burn and Wound Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
An Open Label Study Evaluating the Safety and Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Dermatomyositis
Status: Enrolling
Updated:  7/22/2011
Stanford University School of Medicine
mi
from
Stanford, CA
A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
An Open Label Study Evaluating the Safety and Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Dermatomyositis
Status: Enrolling
Updated: 7/22/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military Trainees
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military Trainees
Status: Enrolling
Updated:  7/28/2011
Usa Meddac Mach
mi
from
Columbus, GA
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military Trainees
Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military Trainees
Status: Enrolling
Updated: 7/28/2011
Usa Meddac Mach
mi
from
Columbus, GA
Click here to add this to my saved trials
Cast Sores With Waterproof Vs. Standard Cast Padding
Cast Sores With Waterproof Vs. Standard Cast Padding in a Pediatric Population
Status: Enrolling
Updated:  8/4/2011
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Cast Sores With Waterproof Vs. Standard Cast Padding
Cast Sores With Waterproof Vs. Standard Cast Padding in a Pediatric Population
Status: Enrolling
Updated: 8/4/2011
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
VA Medical Center, Long Beach
mi
from
Long Beach, CA
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
VA Medical Center, Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Santa Clara Valley Medical Center
mi
from
San Jose, CA
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Carolinas Research
mi
from
Charlotte, NC
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Carolinas Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Status: Enrolling
Updated:  10/22/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Status: Enrolling
Updated: 10/22/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Los Angeles, CA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Miami, FL
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Athens, GA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Chicago, IL
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Hazard, KY
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Boston, MA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Santa Fe, NM
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Brooklyn, NY
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Fort Worth, TX
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
American Fork, UT
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated:  11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
A Phase 2b Study of LY3009104 in Participants With Moderate to Severe Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of LY3009104 in Patients With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling
Updated: 11/9/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.
A 12-week, Single Site, Randomized Controlled Trial to Compare the Efficacy of Quantum NPWT With and Without Simultaneous Irrigation Versus Standard of Care on Reduction of the Volume of Stage III/IV Pressure Ulcers.
Status: Enrolling
Updated:  11/27/2012
Henry Ford Hospital System
mi
from
Detroit, MI
Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.
A 12-week, Single Site, Randomized Controlled Trial to Compare the Efficacy of Quantum NPWT With and Without Simultaneous Irrigation Versus Standard of Care on Reduction of the Volume of Stage III/IV Pressure Ulcers.
Status: Enrolling
Updated: 11/27/2012
Henry Ford Hospital System
mi
from
Detroit, MI
Click here to add this to my saved trials
Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
A Prospective, Longitudinal Assessment of Disease Severity in Subjects With Dystrophic Epidermolysis Bullosa (DEB)
Status: Enrolling
Updated:  2/1/2013
Stanford University School of Medicine
mi
from
Stanford, CA
Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
A Prospective, Longitudinal Assessment of Disease Severity in Subjects With Dystrophic Epidermolysis Bullosa (DEB)
Status: Enrolling
Updated: 2/1/2013
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Clinical Trial Comparing Standard Wound Closure Techniques Versus TissuGlu® Surgical Adhesive
A Clinical Investigation for a Randomized Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques Plus TissuGlu® and No Drains (Test) During Abdominoplasty
Status: Enrolling
Updated:  2/12/2013
The Hunstad Kortesis Center for Cosmetic Plastic Surgery and MedSpa
mi
from
Huntersville, NC
Clinical Trial Comparing Standard Wound Closure Techniques Versus TissuGlu® Surgical Adhesive
A Clinical Investigation for a Randomized Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques Plus TissuGlu® and No Drains (Test) During Abdominoplasty
Status: Enrolling
Updated: 2/12/2013
The Hunstad Kortesis Center for Cosmetic Plastic Surgery and MedSpa
mi
from
Huntersville, NC
Click here to add this to my saved trials
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration
Status: Enrolling
Updated:  2/20/2013
Massachussetts Eye & Ear Infirmary
mi
from
Boston, MA
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration
Status: Enrolling
Updated: 2/20/2013
Massachussetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Status: Enrolling
Updated:  2/20/2013
Stanford School of Medicine
mi
from
Palo Alto, CA
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Status: Enrolling
Updated: 2/20/2013
Stanford School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated:  6/11/2013
San Diego Veterans Affairs Medical Center
mi
from
La Jolla, CA
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated: 6/11/2013
San Diego Veterans Affairs Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated:  6/11/2013
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated: 6/11/2013
UCLA David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated:  6/11/2013
Institute for Allergy and Asthma
mi
from
Wheaton, MD
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated: 6/11/2013
Institute for Allergy and Asthma
mi
from
Wheaton, MD
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated:  6/11/2013
Penn State University
mi
from
Hershey, PA
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated: 6/11/2013
Penn State University
mi
from
Hershey, PA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated:  6/11/2013
AARA Research Center
mi
from
Dallas, TX
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)
Status: Enrolling
Updated: 6/11/2013
AARA Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
The Effects of Emollient Therapy on the Skin Barrier
The Effects of Emollient Therapy on the Skin Barrier Function
Status: Enrolling
Updated:  6/19/2013
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
The Effects of Emollient Therapy on the Skin Barrier
The Effects of Emollient Therapy on the Skin Barrier Function
Status: Enrolling
Updated: 6/19/2013
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Status: Enrolling
Updated:  6/20/2013
Woodrow Wilson Rehabilitation Center
mi
from
Fishersville, VA
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Status: Enrolling
Updated: 6/20/2013
Woodrow Wilson Rehabilitation Center
mi
from
Fishersville, VA
Click here to add this to my saved trials
Evaluate Reversal of Pathological Epidermal Phenotype in Severe Atopic Dermatitis (AD) With Suppression of Immune Activation During Cyclosporine A Therapy
A Study to Evaluate Reversal of the Pathological Epidermal Phenotype in Severe AD With Suppression of Immune Activation During Cyclosporine A Therapy
Status: Enrolling
Updated:  7/3/2013
Rockefeller University
mi
from
New York, NY
Evaluate Reversal of Pathological Epidermal Phenotype in Severe Atopic Dermatitis (AD) With Suppression of Immune Activation During Cyclosporine A Therapy
A Study to Evaluate Reversal of the Pathological Epidermal Phenotype in Severe AD With Suppression of Immune Activation During Cyclosporine A Therapy
Status: Enrolling
Updated: 7/3/2013
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
A Multicenter, Prospective Study to Evaluate CLn® BodyWash As An Adjunctive Therapy in Pediatric Subjects With Moderate to Severe, Staphylococcus Aureus Colonized Atopic Dermatitis
Status: Enrolling
Updated:  7/13/2013
Northwestern University Department of Dermatology
mi
from
Chicago, IL
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
A Multicenter, Prospective Study to Evaluate CLn® BodyWash As An Adjunctive Therapy in Pediatric Subjects With Moderate to Severe, Staphylococcus Aureus Colonized Atopic Dermatitis
Status: Enrolling
Updated: 7/13/2013
Northwestern University Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
A Multicenter, Prospective Study to Evaluate CLn® BodyWash As An Adjunctive Therapy in Pediatric Subjects With Moderate to Severe, Staphylococcus Aureus Colonized Atopic Dermatitis
Status: Enrolling
Updated:  7/13/2013
University of Texas Medical School in Houston
mi
from
Houston, TX
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
A Multicenter, Prospective Study to Evaluate CLn® BodyWash As An Adjunctive Therapy in Pediatric Subjects With Moderate to Severe, Staphylococcus Aureus Colonized Atopic Dermatitis
Status: Enrolling
Updated: 7/13/2013
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.
Status: Enrolling
Updated:  7/13/2013
Ohio State University
mi
from
Gahanna, OH
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.
Status: Enrolling
Updated: 7/13/2013
Ohio State University
mi
from
Gahanna, OH
Click here to add this to my saved trials
Ramipril for the Treatment of Oligospermia
Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial
Status: Enrolling
Updated:  9/5/2013
Weill Cornell Medical College Department of Urology
mi
from
New York, NY
Ramipril for the Treatment of Oligospermia
Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial
Status: Enrolling
Updated: 9/5/2013
Weill Cornell Medical College Department of Urology
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
Pfizer Investigational Site
mi
from
Clifton, NJ
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Clifton, NJ
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
Pfizer Investigational Site
mi
from
Burke, VA
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
Adaption of the Skin Sun Sensitivity Scale
Adaption of the Skin Sun Sensitivity Scale for People With All Pigment Varieties
Status: Enrolling
Updated:  11/1/2013
Northwestern University
mi
from
Chicago, IL
Adaption of the Skin Sun Sensitivity Scale
Adaption of the Skin Sun Sensitivity Scale for People With All Pigment Varieties
Status: Enrolling
Updated: 11/1/2013
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated:  11/7/2013
United States, Arizona
mi
from
Scottsdale, AZ
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated: 11/7/2013
United States, Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated:  11/7/2013
United States, California
mi
from
Granada Hills, CA
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated: 11/7/2013
United States, California
mi
from
Granada Hills, CA
Click here to add this to my saved trials
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated:  11/7/2013
United States, California
mi
from
Los Angeles, CA
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated: 11/7/2013
United States, California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated:  11/7/2013
United States, California
mi
from
Redding, CA
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated: 11/7/2013
United States, California
mi
from
Redding, CA
Click here to add this to my saved trials
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated:  11/7/2013
United States, Georgia
mi
from
Atlanta, GA
Patient Registry Study of Berinert® in Normal Clinical Practice
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Status: Enrolling
Updated: 11/7/2013
United States, Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials